| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.099 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |